Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | United States | $681.98M | 26,723,332 | 86.90% | 13.10% | Net Selling | Net Selling |
GMAB | GENMAB A | Denmark | $20.07B | 66,067,481 | 71.65% | 0.00% | ||
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | United States | $1.70B | 58,571,944 | 61.68% | 38.32% | Net Selling | |
ZYME | ZYMEWORKS INC | Canada | $611.12M | 70,001,987 | 60.37% | 39.63% | Net Buying | |
VYGR | VOYAGER THERAPEUTICS INC | United States | $303.57M | 43,995,363 | 47.73% | 52.27% | Net Buying | Net Selling |
INCY | INCYTE CORP | United States | $11.81B | 224,109,238 | 78.84% | 21.16% | Net Selling | Net Selling |
CPRX | CATALYST PHARMACEUTICALS INC | United States | $1.51B | 106,611,456 | 75.93% | 17.33% | Net Buying | |
FBIO | FORTRESS BIOTECH INC | United States | $17.44M | 8,942,751 | 55.71% | 44.29% | Net Buying | Net Buying |
UTHR | UNITED THERAPEUTICS CORP | United States | $10.83B | 46,993,601 | 87.40% | 12.60% | Net Selling | Net Selling |
MEIP | MEI PHARMA INC | United States | $40.91M | 6,662,857 | 14.83% | 85.17% | Net Buying | Net Buying |
AMLX | AMYLYX PHARMACEUTICALS INC | United States | $871.65M | 67,517,753 | 52.27% | 47.73% | Net Selling | Net Buying |
HALO | HALOZYME THERAPEUTICS INC | United States | $5.24B | 132,098,110 | 77.88% | 22.12% | Net Selling | Net Buying |
BMRN | BIOMARIN PHARMACEUTICAL INC | United States | $16.53B | 188,368,171 | 94.07% | 1.48% | Net Selling | |
LGND | LIGAND PHARMACEUTICALS INC | United States | $1.01B | 17,435,958 | 14.59% | 85.41% | Net Selling | Net Buying |
EXEL | EXELIXIS INC | United States | $6.55B | 310,974,113 | 83.99% | 3.62% | Net Selling | Net Selling |
OCUP | OCUPHIRE PHARMA INC | United States | $61.12M | 22,637,600 | 1.25% | 98.75% | ||
PLX | PROTALIX BIOTHERAPEUTICS INC | Israel | $99.21M | 72,952,124 | 6.32% | 93.68% | Net Buying | Net Buying |
OBIO | ORCHESTRA BIOMED HOLDINGS INC | United States | $232.69M | 35,743,972 | 36.63% | 49.04% | Net Buying | |
CRSP | CRISPR THERAPEUTICS AG | Switzerland | $5.61B | 79,432,446 | 62.71% | 37.29% | Net Buying | |
MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | United States | $1.29B | 251,282,658 | 35.23% | 64.77% | Net Selling | Net Selling |
AGIO | AGIOS PHARMACEUTICALS INC | United States | $1.24B | 55,891,284 | 74.98% | 25.02% | Net Selling | Net Selling |
TECH | BIO-TECHNE CORP | United States | $9.75B | 158,150,379 | 94.93% | 2.36% | Net Buying | Net Buying |
CRNX | CRINETICS PHARMACEUTICALS INC | United States | $2.09B | 66,799,257 | 84.76% | 15.24% | Net Selling | Net Buying |
CORT | CORCEPT THERAPEUTICS INC | United States | $2.62B | 103,081,357 | 29.98% | 70.02% | Net Buying | Net Buying |
ALLO | ALLOGENE THERAPEUTICS INC | United States | $434.15M | 168,276,662 | 62.00% | 38.00% | Net Selling | |
VNDA | VANDA PHARMACEUTICALS INC | United States | $204.24M | 57,531,999 | 57.42% | 42.58% | Net Selling | |
MRKR | MARKER THERAPEUTICS INC | United States | $25.07M | 8,889,020 | 1.28% | 98.72% | ||
AXSM | AXSOME THERAPEUTICS INC | United States | $3.11B | 47,319,547 | 70.49% | 29.51% | Net Selling | Net Selling |
LIFE | ATYR PHARMA INC | United States | $73.20M | 58,560,061 | 63.41% | 26.02% | Net Buying | Net Buying |
CLGN | COLLPLANT BIOTECHNOLOGIES LTD | Israel | $65.35M | 11,405,394 | 13.40% | 0.00% | ||
SPRO | SPERO THERAPEUTICS INC | United States | $61.48M | 52,999,317 | 26.76% | 62.75% | Net Selling | Net Selling |
MGNX | MACROGENICS INC | United States | $464.60M | 62,029,447 | 71.25% | 28.75% | Net Buying | Net Buying |
CRMD | CORMEDIX INC | United States | $184.17M | 54,812,042 | 32.61% | 10.43% | Net Buying | Net Buying |
REGN | REGENERON PHARMACEUTICALS INC | United States | $87.28B | 108,946,984 | 69.06% | 30.94% | Net Selling | Net Selling |
ENTX | ENTERA BIO LTD | Israel | $20.23M | 28,813,952 | 8.95% | 4.08% | Net Buying | |
SPRY | ARS PHARMACEUTICALS INC | United States | $462.23M | 95,997,252 | 45.22% | 54.78% | Net Buying | Net Buying |
LUMO | LUMOS PHARMA INC | United States | $23.82M | 7,914,582 | 18.18% | 81.82% | Net Selling | |
DNLI | DENALI THERAPEUTICS INC | United States | $2.53B | 138,196,848 | 55.82% | 44.18% | Net Selling | Net Selling |
KNSA | KINIKSA PHARMACEUTICALS LTD | Bermuda | $1.10B | 70,338,354 | 49.57% | 10.00% | Net Selling | Net Selling |
VRTX | VERTEX PHARMACEUTICALS INC | United States | $89.43B | 257,683,184 | 89.97% | 1.48% | Net Selling | Net Selling |
ADMA | ADMA BIOLOGICS INC | United States | $840.60M | 225,967,668 | 75.02% | 24.98% | Net Selling | Net Buying |
ARDX | ARDELYX INC | United States | $949.44M | 232,137,709 | 36.14% | 63.86% | Net Selling | Net Selling |
APRE | APREA THERAPEUTICS INC | United States | $14.01M | 3,736,673 | 1.46% | 98.54% | Net Buying | |
BLUE | BLUEBIRD BIO INC | United States | $419.85M | 109,336,211 | 81.79% | 11.59% | Net Selling | Net Selling |
KZR | KEZAR LIFE SCIENCES INC | United States | $63.10M | 72,692,963 | 76.33% | 21.80% | Net Selling | |
RNA | AVIDITY BIOSCIENCES INC | United States | $524.64M | 74,101,254 | 83.37% | 16.63% | Net Buying | |
BGNE | BEIGENE LTD | Cayman Islands | $19.35B | 1,359,497,624 | 3.47% | 34.77% | Net Selling | Net Selling |
RNAC | CARTESIAN THERAPEUTICS INC | United States | $166.84M | 155,204,182 | 33.13% | 42.09% | Net Selling | Net Selling |
PLUR | PLURI INC | Israel | $24.47M | 41,480,172 | 0.52% | 99.48% | Net Selling | |
DBVT | DBV TECHNOLOGIES SA | France | $152.71M | 96,288,553 | 46.10% | 15.38% | Net Buying | |
FUSN | FUSION PHARMACEUTICALS INC | Canada | $343.20M | 72,405,840 | 67.01% | 32.99% | ||
VERV | VERVE THERAPEUTICS INC | United States | $760.57M | 63,752,748 | 60.73% | 39.27% | Net Buying | |
CBAY | CYMABAY THERAPEUTICS INC | United States | $2.04B | 113,403,353 | 86.57% | 13.43% | Net Buying | Net Buying |
LPCN | LIPOCINE INC | United States | $13.13M | 5,315,830 | 5.94% | 94.06% | Net Buying | |
IMGN | IMMUNOGEN INC | United States | $4.25B | 266,264,274 | 91.64% | 3.03% | Net Buying | Net Selling |
ALT | ALTIMMUNE INC | United States | $167.10M | 53,728,871 | 32.55% | 67.45% | Net Buying | |
IGMS | IGM BIOSCIENCES INC | United States | $338.69M | 58,394,056 | 38.22% | 52.45% | Net Buying | Net Selling |
CGEN | COMPUGEN LTD | Israel | $56.91M | 88,233,766 | 14.30% | 0.00% | ||
XCUR | EXICURE INC | United States | $4.32M | 8,648,307 | 0.95% | 99.05% | Net Selling | |
FRTX | FRESH TRACKS THERAPEUTICS INC | United States | $4.71M | 5,973,306 | 1.04% | 98.96% | Net Selling | Net Selling |
FULC | FULCRUM THERAPEUTICS INC | United States | $281.91M | 61,822,554 | 62.18% | 37.82% | Net Buying | |
IMMP | IMMUTEP LTD | Australia | $220.84M | 1,187,306,209 | 0.16% | 0.00% | ||
IDYA | IDEAYA BIOSCIENCES INC | United States | $1.99B | 64,459,472 | 88.86% | 11.14% | Net Buying | Net Selling |
DNTH | DIANTHUS THERAPEUTICS INC | United States | $171.59M | 14,817,762 | 28.11% | 71.89% | Net Selling | Net Buying |
ANIX | ANIXA BIOSCIENCES INC | United States | $103.77M | 31,070,022 | 12.64% | 86.79% | Net Buying | Net Buying |
PGEN | PRECIGEN INC | United States | $278.79M | 248,919,096 | 24.34% | 72.12% | Net Buying | Net Buying |
KRYS | KRYSTAL BIOTECH INC | United States | $2.85B | 28,206,330 | 74.63% | 25.37% | Net Selling | Net Selling |
CMRX | CHIMERIX INC | United States | $84.45M | 88,891,300 | 45.13% | 31.74% | Net Buying | Net Buying |
BCYC | BICYCLE THERAPEUTICS PLC | United Kingdom | $588.39M | 42,421,548 | 62.65% | 37.35% | Net Selling | Net Selling |
ORTX | ORCHARD THERAPEUTICS PLC | United Kingdom | $369.18M | 227,610,439 | 7.28% | 13.37% | Net Buying | |
LSTA | LISATA THERAPEUTICS INC | United States | $20.27M | 8,139,449 | 0.78% | 99.22% | Net Selling | Net Selling |
PRTA | PROTHENA CORP PUBLIC LTD CO | Ireland | $1.74B | 53,665,349 | 52.72% | 47.28% | Net Buying | Net Buying |
FBRX | FORTE BIOSCIENCES INC | United States | $16.82M | 36,335,105 | 45.96% | 21.83% | Net Buying | Net Selling |
CRDF | CARDIFF ONCOLOGY INC | United States | $55.85M | 44,677,169 | 12.21% | 34.53% | Net Buying | Net Buying |
ALDX | ALDEYRA THERAPEUTICS INC | United States | $158.82M | 58,822,083 | 64.21% | 33.43% | Net Selling | Net Selling |
ATOS | ATOSSA THERAPEUTICS INC | United States | $97.49M | 125,304,064 | 12.90% | 15.20% | Net Buying | Net Selling |
JAZZ | JAZZ PHARMACEUTICALS PLC | Ireland | $7.21B | 62,956,913 | 26.62% | 73.38% | Net Selling | Net Selling |
YMAB | Y-MABS THERAPEUTICS INC | United States | $253.01M | 43,621,618 | 45.12% | 38.03% | Net Buying | Net Selling |
NRBO | NEUROBO PHARMACEUTICALS INC | United States | $16.69M | 38,812,518 | 1.05% | 67.02% | ||
LXRX | LEXICON PHARMACEUTICALS INC | United States | $269.42M | 244,924,695 | 21.06% | 78.94% | Net Buying | Net Buying |
ARVN | ARVINAS INC | United States | $1.34B | 55,025,504 | 69.10% | 30.90% | Net Selling | |
GTHX | G1 THERAPEUTICS INC | United States | $87.62M | 51,843,669 | 21.11% | 46.30% | Net Selling | |
ATXS | ASTRIA THERAPEUTICS INC | United States | $166.60M | 36,296,191 | 62.52% | 37.48% | Net Buying | Net Buying |
CUE | CUE BIOPHARMA INC | United States | $103.78M | 45,123,281 | 31.06% | 10.04% | Net Buying | |
PRTC | PURETECH HEALTH PLC | United States | $576.63M | 278,566,306 | 0.03% | 0.00% | ||
AVXL | ANAVEX LIFE SCIENCES CORP | United States | $556.55M | 82,086,511 | 30.50% | 5.04% | Net Buying | |
LQDA | LIQUIDIA CORP | United States | $458.88M | 64,905,495 | 33.30% | 66.70% | Net Selling | Net Selling |
AUPH | AURINIA PHARMACEUTICALS INC | Canada | $1.25B | 143,608,164 | 34.77% | 2.40% | Net Selling | |
AUTL | AUTOLUS THERAPEUTICS PLC | United Kingdom | $791.41M | 173,936,794 | 63.54% | 0.00% | ||
DOMH | DOMINARI HOLDINGS INC | United States | $12.08M | 5,345,312 | 8.37% | 91.63% | Net Buying | Net Buying |
ZLAB | ZAI LAB LTD | China | $2.77B | 988,387,430 | 3.98% | 1.97% | Net Buying | Net Buying |
PBYI | PUMA BIOTECHNOLOGY INC | United States | $195.04M | 47,571,332 | 54.04% | 44.54% | Net Buying | Net Selling |
GRTS | GRITSTONE BIO INC | United States | $123.94M | 95,342,055 | 50.99% | 22.69% | Net Buying | |
SEER | SEER INC | United States | $106.59M | 63,825,213 | 56.70% | 43.30% | Net Buying | Net Buying |
PNT | POINT BIOPHARMA GLOBAL INC | United States | $1.47B | 106,569,231 | 57.83% | 22.10% | Net Buying | |
NVO | NOVO NORDISK A S | Denmark | $462.52B | 4,560,000,000 | 6.56% | 0.00% | ||
GNFT | GENFIT SA | France | $161.96M | 49,834,983 | 2.32% | 0.00% | ||
VTGN | VISTAGEN THERAPEUTICS INC | United States | $100.53M | 27,023,038 | 9.82% | 90.18% | Net Buying | |
ARQT | ARCUTIS BIOTHERAPEUTICS INC | United States | $192.54M | 94,382,074 | 70.70% | 29.30% | Net Buying | Net Buying |
BRTX | BIORESTORATIVE THERAPIES INC | United States | $9.23M | 4,706,917 | 0.36% | 99.64% | Net Buying | Net Buying |